Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2159-2167
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2159
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2159
Treatment | Options | Comments |
Corticosteroids | Prednisolone | If MDF ≥ 32: 40 mg daily orally for 28 d followed by a 2/4-wk taper |
Phosphodiesterase inhibitors | Pentoxyfilline | 400 mg orally 3 times daily for 4 wk |
Anti TNF-α | Infliximab | Infliximab 5 mg/kg iv at day 0 and prednisone 40 mg/d for 28 d (data not confirmed) |
Nutrition | Eating, tube feeding | Diet rich in carbohydrate- and protein-derived calories; potassium replacement; vitamin supplementation |
Antioxidant | Metadoxine | 1500 mg/d orally for 3 mo |
Antioxidant | S-adenosylmethionine | 1200 mg/d orally in ambulatory patients |
Alcohol abstinence | Rehab program disulfiram, naltrexone, acamprosate, baclofen | Reduce alcohol withdrawal symptoms, alcohol craving and intake, promote abstinence, evaluation for OLT program |
- Citation: Abenavoli L, Milic N, Rouabhia S, Addolorato G. Pharmacotherapy of acute alcoholic hepatitis in clinical practice. World J Gastroenterol 2014; 20(9): 2159-2167
- URL: https://www.wjgnet.com/1007-9327/full/v20/i9/2159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i9.2159